Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis-Reference-Cited by-同舟云学术

Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis

Published:2008-04-23 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Clerico Marinella¹,Faggiano Fabrizio²,Palace Jaqueline³,Rice George PA⁴,Tintorè Subirana Mar⁵,Durelli Luca¹

Affiliation:

1. San Luigi Gonzaga University Hospital; Clinical and Biological Science Department, University of Torino; Regione Gonzole, 10 Orbassano Torino Italy 10043

2. University of Piemonte Orientale A. Avogadro; Department of Medical Sciences; Via Santena 5 bis Novara Italy 28100

3. Radcliff Infirmary Hospital; University Department of Clinical Neurology; Woodstock Road Oxford UK OX20HE

4. University of Western Ontario; Clinical Neurological Sciences; 339 Windermere Road London Ontario Canada N6A 5A5

5. Vall d'Hebròn University Hospital; Clinical Neuroimmunology Unit; Pg. Vall d'Hebron 119-129 Barcelona Spain 08035

Publisher

Wiley

Subject

Pharmacology (medical)

Reference33 articles.

1. Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes;Kappos;Neurology,2006

2. Interferon beta-1a for early multiple sclerosis: CHAMPS trial subgroup analyses;Beck;Annals of Neurology,2002

3. Interferon B-1a for Optic Neuritis Patients at High Risk for Multiple Sclerosis;CHAMPS STUDY GROUP;American Journal of Ophtalmology,2001

4. Intramuscolar interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group;Jacobs;New England Journal of Medicine,2000

5. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study;Comi;Lancet,2001

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What are the effects of recombinant interferon beta for delaying conversion of the first demyelinating event to multiple sclerosis (MS)?;Cochrane Clinical Answers;2021-04-13

2. Systematic review and meta-analysis of the development of multiple sclerosis in clinically isolated syndrome;European Journal of Ophthalmology;2020-12-29

3. Current Requirements for Studies of Drugs for the Pathogenetic Treatment of Multiple Sclerosis;Неврология и нейрохирургия. Восточная Европа;2020-04-29

4. Cost-effectiveness of interferon therapy for multiple sclerosis in Peru: impact of treatment adherence;Journal of Pharmaceutical Health Services Research;2019-01-11

5. Comparative effectiveness of beta-interferons and glatiramer acetate for relapsing-remitting multiple sclerosis: systematic review and network meta-analysis of trials including recommended dosages;BMC Neurology;2018-10-03